Huang X - Search Results

1

Predicting valuable missense variants with AlphaMissense in a multiple pulmonary infection patient.

Wang T, Ma J, Shu Y, Hong B, Wang Z, Lu Y, Yu X, Huang X, Zhang Y. Wang T, et al. Among authors: huang x. Clin Case Rep. 2024 Jan 30;12(2):e8453. doi: 10.1002/ccr3.8453. eCollection 2024 Feb. Clin Case Rep. 2024. PMID: 38292225 Free PMC article.

2

[Active screening of intestinal carbapenem-resistant Enterobacteriaceae in high-risk patients admitted to the hematology wards and its effect evaluation].

Huang XL, Wu SH, Shi PF, Xu LH, Chen C, Xie YP, Gao DQ, Chen K, Tan JF, Liu LR, Xu Y, Yang F, Yu MX, Wang SY, Qian SX. Huang XL, et al. Zhonghua Xue Ye Xue Za Zhi. 2020 Nov 14;41(11):932-936. doi: 10.3760/cma.j.issn.0253-2727.2020.11.009. Zhonghua Xue Ye Xue Za Zhi. 2020. PMID: 33333697 Free PMC article. Chinese.

3

Dihydroartemisinin Modulates Apoptosis and Autophagy in Multiple Myeloma through the P38/MAPK and Wnt/β-Catenin Signaling Pathways.

Wu X, Liu Y, Zhang E, Chen J, Huang X, Yan H, Cao W, Qu J, Gu H, Xu R, He J, Cai Z. Wu X, et al. Among authors: huang x. Oxid Med Cell Longev. 2020 Aug 15;2020:6096391. doi: 10.1155/2020/6096391. eCollection 2020. Oxid Med Cell Longev. 2020. PMID: 32879652 Free PMC article.

4

Cardamonin reduces chemotherapy resistance of colon cancer cells via the TSP50/NF-κB pathway in vitro.

Lu S, Lin C, Cheng X, Hua H, Xiang T, Huang Y, Huang X. Lu S, et al. Among authors: huang x, huang y. Oncol Lett. 2018 Jun;15(6):9641-9646. doi: 10.3892/ol.2018.8580. Epub 2018 Apr 26. Oncol Lett. 2018. PMID: 29928339 Free PMC article.

5

Identification of key candidate genes and pathways in multiple myeloma by integrated bioinformatics analysis.

Yan H, Zheng G, Qu J, Liu Y, Huang X, Zhang E, Cai Z. Yan H, et al. Among authors: huang x. J Cell Physiol. 2019 Dec;234(12):23785-23797. doi: 10.1002/jcp.28947. Epub 2019 Jun 18. J Cell Physiol. 2019. PMID: 31215027 Free PMC article.

6

Integrated bioinformatic analysis of HNF1A in human cancers.

Zhang E, Huang X, He J. Zhang E, et al. Among authors: huang x. J Int Med Res. 2021 Mar;49(3):300060521997326. doi: 10.1177/0300060521997326. J Int Med Res. 2021. PMID: 33752475 Free PMC article.

7

NEDD4L binds the proteasome and promotes autophagy and bortezomib sensitivity in multiple myeloma.

Huang X, Cao W, Yao S, Chen J, Liu Y, Qu J, Li Y, Han X, He J, Huang H, Zhang E, Cai Z. Huang X, et al. Among authors: huang h. Cell Death Dis. 2022 Mar 2;13(3):197. doi: 10.1038/s41419-022-04629-8. Cell Death Dis. 2022. PMID: 35236820 Free PMC article.

8

The NEDD4-1 E3 ubiquitin ligase: A potential molecular target for bortezomib sensitivity in multiple myeloma.

Huang X, Gu H, Zhang E, Chen Q, Cao W, Yan H, Chen J, Yang L, Lv N, He J, Yi Q, Cai Z. Huang X, et al. Int J Cancer. 2020 Apr 1;146(7):1963-1978. doi: 10.1002/ijc.32615. Epub 2019 Aug 24. Int J Cancer. 2020. PMID: 31390487 Free PMC article.

9

CUDC-101 as a dual-target inhibitor of EGFR and HDAC enhances the anti-myeloma effects of bortezomib by regulating G2/M cell cycle arrest.

Cao W, Yao S, Li A, Chen H, Zhang E, Cao L, Zhang J, Hou Y, Dai Z, Chen J, Huang X, Yang L, Cai Z. Cao W, et al. Among authors: huang x. J Zhejiang Univ Sci B. 2023 May 15;24(5):442-454. doi: 10.1631/jzus.B2200465. J Zhejiang Univ Sci B. 2023. PMID: 37190893 Free PMC article.

10

Role of interleukin-32 in cancer biology.

Yan H, He D, Huang X, Zhang E, Chen Q, Xu R, Liu X, Zi F, Cai Z. Yan H, et al. Among authors: huang x. Oncol Lett. 2018 Jul;16(1):41-47. doi: 10.3892/ol.2018.8649. Epub 2018 May 7. Oncol Lett. 2018. PMID: 29930712 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

44,026 results

Search Page